Medikamentenvergleiche
Semaglutide vs. Sotagliflozin
Compare Semaglutide (Ozempic) vs Sotagliflozin (Inpefa): GLP-1 vs dual SGLT inhibitor for T2D, weight loss, and heart failure. See which may be better.
Für diese Seite sind keine Vergleichsdimensionen verfügbar.
Klinischer Kontext
This comparison is triggered for type 2 diabetes patients who also have heart failure or high cardiovascular risk, weighing a GLP-1 agonist against a dual SGLT inhibitor.
Fazit
Semaglutide is generally stronger for weight reduction and A1C lowering, while Sotagliflozin offers distinct cardiorenal protection, so the better option is highly patient-specific.
Alle Medikamentenvergleiche